[VIRTUAL] CROSSING OUR T'S: AN UNUSUAL PRESENTATION OF INFANTILE T-CELL LEUKEMIA (ASPHO 2021)
The paucity of data regarding infantile T-ALL’s clinical presentation, management, genomics, and outcomes results in difficult treatment decisions including potential use of agents such as Nelarabine, at a young age... We report a unique case of infantile T-ALL, treated initially per COG protocol AALL0631. With CSF3Rmutations association to GCSF, being an unusual finding. Additionally, LMO2 overexpression is a common driver of T-Cell malignancies, however, has not been reported in infantile T-ALL.